Albendazole
From Wikipedia, the free encyclopedia
 |
|
|
Albendazole
|
|
| Systematic (IUPAC) name | |
| methyl [(5-propylsulfanyl-3H- benzoimidazol-2-yl) amino]formate | |
| Identifiers | |
| CAS number | |
| ATC code | P02 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C12H15N3O2S |
| Mol. mass | 265.333 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
D |
| Legal status | |
| Routes | ? |
Albendazole, marketed as Albenza, Eskazole or Zentel, is a member of the benzimidazole compounds used as a drug indicated for the treatment of a variety of worm infestations. Although this use is widespread in the United States, the FDA has not approved albendazole for this indication.
It is effective against
[edit] Mode of Action
It blocks parasitic glucose uptake by interrupting microtubular function.
[edit] Pregnancy Class
D (Australia) - Do not take when pregnant, and do not become pregnant for one month after taking this drug.
 |
This article about a heterocyclic compound is a stub. You can help Wikipedia by expanding it. |
 |
This molecular or cell biology article is a stub. You can help Wikipedia by expanding it. |
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
